111 related articles for article (PubMed ID: 15875780)
1. Transcriptome analysis of different multidrug-resistant gastric carcinoma cells.
Heim S; Lage H
In Vivo; 2005; 19(3):583-90. PubMed ID: 15875780
[TBL] [Abstract][Full Text] [Related]
2. Identification of differentially expressed genes in classical and atypical multidrug-resistant gastric carcinoma cells.
Ludwig A; Dietel M; Lage H
Anticancer Res; 2002; 22(6A):3213-21. PubMed ID: 12530067
[TBL] [Abstract][Full Text] [Related]
3. Selection and characterization of heat-resistant variants of multidrug-resistant human gastric carcinoma cell lines.
Jordan A; Scholz R
Exp Oncol; 2005 Mar; 27(1):18-23. PubMed ID: 15812352
[TBL] [Abstract][Full Text] [Related]
4. Regulation of MDR1 gene expression in multidrug-resistant cancer cells is independent from YB-1.
Kaszubiak A; Kupstat A; Müller U; Hausmann R; Holm PS; Lage H
Biochem Biophys Res Commun; 2007 May; 357(1):295-301. PubMed ID: 17418094
[TBL] [Abstract][Full Text] [Related]
5. Impact of BCRP/MXR, MRP1 and MDR1/P-Glycoprotein on thermoresistant variants of atypical and classical multidrug resistant cancer cells.
Stein U; Lage H; Jordan A; Walther W; Bates SE; Litman T; Hohenberger P; Dietel M
Int J Cancer; 2002 Feb; 97(6):751-60. PubMed ID: 11857350
[TBL] [Abstract][Full Text] [Related]
6. Stable and complete overcoming of MDR1/P-glycoprotein-mediated multidrug resistance in human gastric carcinoma cells by RNA interference.
Stege A; Priebsch A; Nieth C; Lage H
Cancer Gene Ther; 2004 Nov; 11(11):699-706. PubMed ID: 15375376
[TBL] [Abstract][Full Text] [Related]
7. Effect of YB-1 on the regulation of micro RNA expression in drug-sensitive and drug-resistant gastric carcinoma cells.
Belian E; Kurucz R; Treue D; Lage H
Anticancer Res; 2010 Feb; 30(2):629-33. PubMed ID: 20332481
[TBL] [Abstract][Full Text] [Related]
8. Membrane vesicle formation due to acquired mitoxantrone resistance in human gastric carcinoma cell line EPG85-257.
Dietel M; Arps H; Lage H; Niendorf A
Cancer Res; 1990 Sep; 50(18):6100-6. PubMed ID: 1975514
[TBL] [Abstract][Full Text] [Related]
9. Regulation of mRNA expression in drug-sensitive and drug-resistant gastric carcinoma cells is independent of YB-1 expression.
Kurucz R; Belian E; Treue D; Lage H
Anticancer Res; 2010 Feb; 30(2):693-8. PubMed ID: 20332492
[TBL] [Abstract][Full Text] [Related]
10. Molecular analysis of therapy resistance in gastric cancer.
Lage H
Dig Dis; 2003; 21(4):326-38. PubMed ID: 14752223
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of terpenoids against classical and atypical multidrug resistant cancer cells.
Lage H; Duarte N; Coburger C; Hilgeroth A; Ferreira MJ
Phytomedicine; 2010 May; 17(6):441-8. PubMed ID: 19682879
[TBL] [Abstract][Full Text] [Related]
12. Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR.
Yang YX; Xiao ZQ; Chen ZC; Zhang GY; Yi H; Zhang PF; Li JL; Zhu G
Proteomics; 2006 Mar; 6(6):2009-21. PubMed ID: 16525997
[TBL] [Abstract][Full Text] [Related]
13. Discovery of differentially expressed genes associated with paclitaxel resistance using cDNA array technology: analysis of interleukin (IL) 6, IL-8, and monocyte chemotactic protein 1 in the paclitaxel-resistant phenotype.
Duan Z; Feller AJ; Penson RT; Chabner BA; Seiden MV
Clin Cancer Res; 1999 Nov; 5(11):3445-53. PubMed ID: 10589757
[TBL] [Abstract][Full Text] [Related]
14. Establishment of hepatocellular carcinoma multidrug resistant monoclone cell line HepG2/mdr1.
Chen YB; Yan ML; Gong JP; Xia RP; Liu LX; Li N; Lu SC; Zhang JG; Zeng DB; Xie JG; Yang JY; Yan LN
Chin Med J (Engl); 2007 Apr; 120(8):703-7. PubMed ID: 17517188
[TBL] [Abstract][Full Text] [Related]
15. Effects of multidrug resistance, antisense RNA on the chemosensitivity of hepatocellular carcinoma cells.
Li B; Ye T; Zhao L; Li DH; Gou XH; Zhao LY; Han L; Chen L; Yan LN; Gong JP
Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):552-9. PubMed ID: 17085341
[TBL] [Abstract][Full Text] [Related]
16. Effects of celecoxib on the reversal of multidrug resistance in human gastric carcinoma by downregulation of the expression and activity of P-glycoprotein.
Huang L; Wang C; Zheng W; Liu R; Yang J; Tang C
Anticancer Drugs; 2007 Oct; 18(9):1075-80. PubMed ID: 17704658
[TBL] [Abstract][Full Text] [Related]
17. Association of genomic imbalances with drug resistance and thermoresistance in human gastric carcinoma cells.
Tönnies H; Poland J; Sinha P; Lage H
Int J Cancer; 2003 Mar; 103(6):752-8. PubMed ID: 12516094
[TBL] [Abstract][Full Text] [Related]
18. RAIDD expression is impaired in multidrug resistant osteosarcoma cell lines.
Yang C; Hornicek FJ; Wood KB; Schwab JH; Mankin H; Duan Z
Cancer Chemother Pharmacol; 2009 Aug; 64(3):607-14. PubMed ID: 19125251
[TBL] [Abstract][Full Text] [Related]
19. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
[TBL] [Abstract][Full Text] [Related]
20. Glypican-3 is involved in cellular protection against mitoxantrone in gastric carcinoma cells.
Wichert A; Stege A; Midorikawa Y; Holm PS; Lage H
Oncogene; 2004 Jan; 23(4):945-55. PubMed ID: 14661052
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
